Cargando…

Association of serum cholesterol with Parkinson's disease in a cohort of statin‐free individuals

INTRODUCTION: The role of serum cholesterol in the pathogenesis of Parkinson's disease (PD) remains unclear. The objective of this study was to assess the association between serum cholesterol and PD in a cohort of statin‐free newly diagnosed PD patients. METHODS: This retrospective study used...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lv, Yukai, Xu, Bo, Zhang, Xuejuan, Chen, Chunhuan, Gao, Yan, Li, Ning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785640/ https://www.ncbi.nlm.nih.gov/pubmed/34894416 http://dx.doi.org/10.1002/brb3.2454

Ejemplares similares

Cholesterol, Statins, and Alzheimer Disease
por: Koudinov, Alexei R, et al.
Publicado: (2005)

Influence of serum cholesterol level and statin treatment on prostate cancer aggressiveness
por: Schnoeller, Thomas J., et al.
Publicado: (2017)

Serum Cholesterol and the Progression of Parkinson's Disease: Results from DATATOP
por: Huang, Xuemei, et al.
Publicado: (2011)

Serum Cholesterol and Nigrostriatal R2* Values in Parkinson's Disease
por: Du, Guangwei, et al.
Publicado: (2012)

Alzheimer's Disease: cholesterol, membrane rafts, isoprenoids and statins
por: Reid, Patrick C, et al.
Publicado: (2007)

Statins: Cholesterol guidelines and Indian perspective
por: Menon, Anil S., et al.
Publicado: (2015)

Cholesterol suppresses antimicrobial effect of statins
por: Haeri, Mohammad Reza, et al.
Publicado: (2015)

Role of Serum Cholesterol and Statin Use in the Risk of Prostate Cancer Detection and Tumor Aggressiveness
por: Morote, Juan, et al.
Publicado: (2014)

Statin adherence and the risk of Parkinson's disease: A population-based cohort study
por: Rozani, Violetta, et al.
Publicado: (2017)

Statins redux: A re-assessment of how statins lower plasma cholesterol
por: Raghow, Rajendra
Publicado: (2017)

Optimal Target Level of Low-density Lipoprotein Cholesterol for Vascular Function in Statin Naïve Individuals
por: Matsui, Shogo, et al.
Publicado: (2017)

Cholesterol Serum Levels and Use of Statins in Graves' Orbitopathy: A New Starting Point for the Therapy
por: Lanzolla, Giulia, et al.
Publicado: (2020)

Racial Differences in the Cholesterol-Lowering Effect of Statin
por: Naito, Ryo, et al.
Publicado: (2017)

Pre-Treatment with Statins for Coronary Intervention: Pleiotropy of Statins or Effect of LDL-cholesterol Reduction?
por: Habon, Tamas, et al.
Publicado: (2016)

Statin treatment and LDL-cholesterol treatment goal attainment among individuals with familial hypercholesterolaemia in primary care
por: Iyen, Barbara, et al.
Publicado: (2021)

Combination therapy in cholesterol reduction: focus on ezetimibe and statins
por: Grigore, Liliana, et al.
Publicado: (2008)

‘Real-life’ reduction in cholesterol with statins, 1993 to 2002
por: Murphy, Michael J, et al.
Publicado: (2008)

Impact of prescription size on statin adherence and cholesterol levels
por: Batal, Holly A, et al.
Publicado: (2007)

Atherosclerosis, cholesterol, nutrition, and statins – a critical review
por: Gebbers, Jan-Olaf
Publicado: (2007)

Anti-Inflammatory Effects of Statins Beyond Cholesterol Lowering
por: Joo, Seung-Jae
Publicado: (2012)

RHOA Is a Modulator of the Cholesterol-Lowering Effects of Statin
por: Medina, Marisa W., et al.
Publicado: (2012)

Of statins and low-density lipoprotein cholesterol, “fats” and fiction
por: Unnikrishnan, Ambika Gopalakrishnan, et al.
Publicado: (2016)

Decreasing cholesterol levels in the community – lifestyle change with statin?
por: Savolainen, Jorma, et al.
Publicado: (2015)

Coronaviruses, cholesterol and statins: Involvement and application for Covid-19
por: Orlowski, Stéphane, et al.
Publicado: (2021)

Forecasting Cholesterol Management-End of the Statin Gold Rush?
por: Crownover, Brian K., et al.
Publicado: (2006)

Effect of statins on Parkinson's disease: A systematic review and meta-analysis
por: Yan, Junqiang, et al.
Publicado: (2019)

Sub-optimal cholesterol response to initiation of statins and future risk of cardiovascular disease
por: Akyea, Ralph Kwame, et al.
Publicado: (2019)

A systematic review and meta-analysis of serum cholesterol and triglyceride levels in patients with Parkinson’s disease
por: Fu, Xiaoxue, et al.
Publicado: (2020)

High LDL cholesterol and statin use were independently associated with lower eight-year mortality in a cohort free from terminal illness, cardiovascular disease, and diabetes at baseline
por: Thulesius, Hans
Publicado: (2014)

Reduced Serum Levels of Triglyceride, Very Low Density Lipoprotein Cholesterol and Apolipoprotein B in Parkinson’s Disease Patients
por: Wei, Qiang, et al.
Publicado: (2013)

HMGCR gene polymorphism is associated with residual cholesterol risk in premature triple-vessel disease patients treated with moderate-intensity statins
por: Li, Jiawen, et al.
Publicado: (2023)

Statins are underused in recent-onset Parkinson's disease with increased vascular risk: findings from the UK Tracking Parkinson's and Oxford Parkinson's Disease Centre (OPDC) discovery cohorts
por: Swallow, Diane M A, et al.
Publicado: (2016)

Statin Use and the Risk of Parkinson's Disease: An Updated Meta-Analysis
por: Bai, Shuang, et al.
Publicado: (2016)

56600 Statin use and medical expenditure in patients with Parkinson’s disease
por: Lo Piccolo, Anthony J., et al.
Publicado: (2021)

Correction: RHOA Is a Modulator of the Cholesterol-Lowering Effects of Statin
por: Medina, Marisa W., et al.
Publicado: (2013)

Influence of Previous Statin Therapy on Cholesterol-Lowering Effect of Ezetimibe
por: Choi, Young Hwan, et al.
Publicado: (2014)

Low-density lipoprotein cholesterol, statin therapy, and cerebral microbleeds: The CIRCLE study
por: Zhao, Yuqi, et al.
Publicado: (2023)

Pros and cons for statins use and risk of Parkinson's disease: An updated perspective
por: Al‐kuraishy, Hayder M., et al.
Publicado: (2023)

LDL-cholesterol change and goal attainment following statin intensity titration among Asians in primary care: a retrospective cohort study
por: Fang, Hao Sen Andrew, et al.
Publicado: (2021)

Cholesterol treatment with statins: Who is left out and who makes it to goal?
por: Franks, Peter, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_5jrm0mi9236s70d0deffb54695